R&D areas-We think a true scientist is a person who walk towards truth with a sense of awe and respect without distorting the truth.We are walking this way today in an undemonstrative fashion to become scientists who embody this tenet.

Targeted cancer drugs

H > Projects > Cancer

 Virus disease therapies

What are targeted drugs?

Conventional cancer therapies cause many adverse effects because they inhibit the division and function of normal cells as well as cancer cells. To overcome this, several targeted drugs are being currently developed. Targeted therapies can block growth, proliferation, angiogenesis, and invasion and metastasis by targeting receptors or signaling pathways that are abnormal. Because this method targets specific receptors and signaling molecules, it is possible to use specific biomarkers to predict which patients may benefit the most from this therapy.

Clinical trials have shown that treating terminal cancer patients with a combination of targeted and conventional therapies (e.g., radiotherapy) results in significantly prolonged survival. Targeted therapies also improve the quality of life for these patients as these therapies have relatively few adverse effects.

What is a targeted drugs?

R&D trends

Currently, a number of targeted therapeutics are being used to treat cancer, including Gleevec (which targets BCL-Abl), Rituxan (targets CD20), Herceptin (targets Her2), Avastin (targets VEGF), and Erbitux, Iressa, and Tarceva (which target EGFR). These therapies are the foundation for personalized cancer treatment.

MOGAM conducts...

Research on targeted therapies. We are committed to using translational research and to develop personalized therapies to take into account the characteristics of each individual patient.